COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 144: Articles 1431-1440  | Next

Impact of cell culture model systems on SARS-CoV-2 and MERS-CoV infection dynamics and antiviral responses
Chiok, K., Fenton, M., Falzarano, D., Dhar, N., Banerjee, A.
10.1101/2025.02.24.639954 — Posted: 2025-02-27
Unveiling the Complete Spectrum of SARS-CoV-2 Fusion Stages by In Situ Cryo-ET
Akil, C., Xu, J., Shen, J., zhang, p.
10.1101/2025.02.25.640151 — Posted: 2025-02-27
Changes in somatic symptoms among people with severe COVID anxiety, before and after the coronavirus pandemic
Grocott, L., King, J. D., Mcquaid, A., Leeson, V. C., Crawford, M. J.
10.1101/2025.02.26.25322939 — Posted: 2025-02-26
A truncated SARS-CoV-2 nucleocapsid protein enhances virus fitness by evading antiviral responses
Mulloy, R. P., Evseev, D., Bui-Marinos, M. P., Sharlin, N., Corcoran, J. A.
10.1101/2025.02.15.638421 — Posted: 2025-02-26
Forecasting protein evolution by integrating birth-death population models with structurally constrained substitution models
Ferreiro, D., Gonzalez-Vazquez, L. D., Prado-Comesana, A., Arenas, M.
10.1101/2025.02.21.639428 — Posted: 2025-02-26
Changes in pneumococcal deaths in the United States following the COVID-19 pandemic
Shang, L., Perniciaro, S., Weinberger, D.
10.1101/2025.02.24.25322782 — Posted: 2025-02-25
Pharmacokinetics of anti-SARS-CoV-2 monoclonal antibody SA55 injection in healthy participants
Zhou, Y., MENG, X., Li, J., Wang, J., Zeng, G., Cao, Y. R., Hu, C., Jin, R.
10.1101/2025.02.22.25322730 — Posted: 2025-02-24
NRF2 activators restrict coronaviruses by targeting a network involving ACE2, TMPRSS2, and XPO1
Waqas, F. H., Zapatero-Belinchon, F. J., Carter-Timofte, M. E., Lasswitz, L., van der Horst, D., Möller, R., Dahlmann, J., Olmer, R., Geffers, R., Gerold, G., Olagnier, D., Pessler, F.
10.1101/2025.02.24.639813 — Posted: 2025-02-24
SARS-CoV-2 nucleocapsid uniquely disrupts chromatin over pathophysiologically relevant gene promoters
Benoit, J. M., Dennis, J. H.
10.1101/2025.02.22.639619 — Posted: 2025-02-24
Flagellin in the human gut microbiome is a diet-adjustable adjuvant for vaccination
Huus, K. E., uHEAT Clinical Study Group, , Tan, Y. H., Abo, H., Keller, R., Atay, E., Vu, D. L., Dauser, S., Prokipchuk, A., Tyakht, A., Youngblut, N., Chassaing, B., Kang, S.-M., Parsonnet, J., Kremsner, P. G., Maier, L., Gewirtz, A. T., Esen, M., Ley, R. E.
10.1101/2025.02.21.639485 — Posted: 2025-02-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).